The Opportunity for Molecular Imaging in Clinical Trials

Table of Contents

• Table of Contents
• Health Industry Insights Opinion
• In This Report
• Situation Overview
  • Introduction
  • Value Proposition for Molecular Imaging
  • Imaging Applications in Clinical Trials
  • Table: Application of Molecular Imaging in Clinical Trials
  • Table: Molecular Imaging Targets for Specific Therapeutic Areas
  • Table: Uses of Imaging Technologies for Clinical Compound Evaluation
  • Table: Benefits and Limitations of Specific Imaging Technologies
  • Imaging in the Clinical Environment
    • Magnetic Resonance Imaging (MRI or MR)
    • Functional MRI (fMRI)
    • Computed Tomography (CT, CAT, or Cat Scans)
    • Figure: Algorithmic Construction of Anatomical Images
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computerized Tomography (SPECT)
    • Ultrasound Imaging
    • Optical Imaging
    • Fusion Modalities
  • Technology/Vendor Market Landscape
  • Figure: Preclinical Imaging Systems Vendor Landscape
  • Figure: Worldwide Imaging Market Share by Modality, 2005
  • Figure: Worldwide Imaging Revenue Share by Segment, 2005
  • Table: Molecular Imaging System Vendors in the Emerging Preclinical Area
    • Clinical Instrument Vendor Landscape
      • GE Healthcare
      • Siemens Medical Solutions
      • Philips Medical Systems
      • All Three
    • MI Contrast Agent Landscape
    • Table: Selected Vendors and Products of Molecular Imaging Contrast Agents
    • CRO Imaging Landscape
    • Table: Selected Imaging CROs
  • Government Efforts to Accelerate MI Adoption
    • MI and the NIH Roadmap for Medical Research
    • FDA and the Critical Path
    • NCI Imaging Efforts
    • Figure: NCI Cancer Imaging Programs Detailed Funding, FY96-FY03
  • Pharmaceutical Industry Adoption of MI in Clinical Trials
  • Factors Affecting the Wider Adoption of MI in Clinical Trials (and in the Hospital)
    • Imaging Technology Considerations
    • Contrast Agent Considerations
    • Infrastructure Considerations
    • Regulatory Considerations
  • Select New Technology Applications in Molecular Imaging
• Future Outlook
  • Rapid Growth Expected in the Imaging Market
  • Table: U.S. Molecular Imaging Instrumentation Revenue, 2004-2009 ($M)
  • Table: Worldwide and U.S. Molecular Imaging Contrast Agent Sales Revenue, 2003-2009 ($M)
• Essential Guidance
  • Actions to Consider
  • Specific Recommendations for Pharmaceutical and CRO R&D Management
• Learn More
  • Related Research
  • Synopsis